Tamedin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tamedin

Quick Facts

Property Description
Active ingredient Cimetidine
Form Tablets, Oral Solution, Parenteral Solution
Pharmacological class Histamine H₂-receptor antagonist
General purpose Reduction of gastric acid secretion
Origin Synthetic organic molecule

What is the Core Identity of Tamedin?

Tamedin is a medicinal preparation whose core component is the active chemical compound Cimetidine. This substance is a synthetic organic molecule classified as an agent for acid-related disorders and is designed as a single active ingredient product for internal administration. It holds the historical distinction of being the first clinically successful and widely adopted agent in its class.

Cimetidine belongs to the Histamine H₂-receptor antagonist class and is structurally an imidazole ring derivative. The drug’s role in public health and its use in managing conditions arising from excess acid are clinically recognized.

How is Tamedin Classified by Action?

Tamedin is formally classified as an H₂-blocker, with the principal objective being the control and reduction of stomach acid production. As a Histamine H₂-receptor antagonist, its mechanism involves the competitive inhibition of histamine, the natural signaling molecule that prompts the stomach's parietal cells to secrete hydrochloric acid.

This targeted action results in a substantial decrease in overall acid output. This offers a key benefit: creating a less aggressive environment in the stomach and upper gastrointestinal tract. A typical use scenario involves its application to alleviate generalized digestive discomfort caused by hyperacidity.

What Physical Forms and Administration Types Exist?

The active compound Cimetidine is made available in several high-level dosage forms to meet diverse clinical requirements. These preparations include oral solid preparations (tablets) and oral liquid preparations (solutions) for patient convenience. For immediate needs or when oral ingestion is impossible, the medication is also available as a sterile parenteral solution suitable for administration via intramuscular or intravenous routes.

Regulatory References

  1. Cimetidine entry in the WHO Electronic Essential Medicines List (eEML)

What side effects are possible with Tamedin?

Possible Side Effects and Safety Information

Adverse reactions associated with Tamedin (Cimetidine) are officially classified by regulatory authorities based on the system or organ they affect, and their documented frequency.


Adverse Reaction Categories

Classification Examples of Reactions Affected Systems (SOC)
Common Headache, diarrhea, dizziness Nervous System, Gastrointestinal
Uncommon Confusion, leukopenia, tachycardia Nervous System, Blood and Lymphatic System, Cardiac
Rare / Very Rare Agranulocytosis, aplastic anemia, hepatitis, cardiac arrhythmias Blood and Lymphatic, Hepatobiliary, Cardiac

Official Safety Profile

The safety profile includes Serious Adverse Reactions, which are rare but clinically significant events documented in regulatory sources. These include blood dyscrasias, such as agranulocytosis and aplastic anemia, and severe Central Nervous System (CNS) effects, specifically confusion and psychotic states, which are generally reversible.

Population-Specific Safety Notes emphasize that older adults and patients with impaired renal function have an increased risk of developing these CNS side effects due to the drug’s clearance characteristics. Furthermore, certain adverse effects, such as gynecomastia, are noted to be associated with long-term use, and most reported adverse reactions are documented as reversible upon discontinuation of treatment. Tamedin is formally contraindicated in individuals with known hypersensitivity to the compound.

Overdose and Emergency Response

Overdose and When to Seek Help

The substance Tamedin (Tianeptine) is not approved for any medical use in the United States, and regulatory warnings focus strictly on the serious risks associated with its misuse, abuse, and potential for overdose. Reported cases of severe adverse events and death are associated with taking doses significantly higher than those approved in other countries, or by combining the substance with other drugs like antidepressants or antianxiety medicines.

Documented Overdose Presentations

Symptoms reported in cases of overdose and toxicity often affect the central nervous, cardiovascular, and respiratory systems. These serious harmful effects can include agitation, confusion, excessive sweating, rapid heartbeat, high blood pressure, and severe gastrointestinal issues like nausea and vomiting. Most critically, overdose can lead to severe sedation, slowed or stopped breathing (respiratory depression), coma, and death. Clinical presentations may mimic opioid toxicity.

Immediate Medical Attention

If you suspect poisoning or overdose, or if an individual is having trouble breathing, is difficult to wake up, or loses consciousness, call emergency services immediately. Due to the substance's potential to cause life-threatening effects, any suspected ingestion of an unknown or high quantity requires urgent medical evaluation. You may also contact the Poison Help Line for guidance.

Therapeutic Uses of Tamedin

What Tamedin Treats: Main Uses and Benefits

Tamedin is an acid reducer that helps manage conditions caused by excess stomach acid. The medicine is commonly used to treat and help manage symptoms associated with acid-related issues.

The main clinical scenarios where Tamedin is used include relieving and preventing heartburn, acid indigestion, and sour stomach. It is also used for maintenance therapy for duodenal ulcers and is indicated for the short-term treatment of active duodenal and benign gastric ulcers, erosive gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions such as Zollinger-Ellison syndrome. The primary benefit patients receive is the reduction of discomforting symptoms like burning sensations and sourness. The medication serves as an “Acid Reducer,” which aids in symptom management.


Quick Fact: Relief for Heartburn Tamedin may help manage discomfort associated with excess stomach acid and aid in the treatment of related ulcers.

Regulatory References

  1. NIH DailyMed Cimetidine Indications

Eligibility and Restrictions for Use

Population Eligibility for Tamedin

Official regulatory documents define strict criteria for who is eligible to use Tamedin (Cimetidine), focusing on absolute contraindications and conditions requiring restricted use.

Contraindications and Absolute Restrictions

Category Regulatory Status
Hypersensitivity Contraindicated in patients with a known hypersensitivity to cimetidine or any excipients in the formulation.
Pregnancy Not recommended; use should only occur if clearly needed, as specified by regulatory labeling.
Lactation Not recommended, as the medicine is excreted in human milk.

Conditional Use and Age Limits

Use of the medicine is established for adults but is generally not recommended for children under 12 years of age for routine indications. Eligibility is subject to specific conditional limitations based on the patient's physiological status:

  • Impaired Renal Function: Requires a dose reduction due to altered drug clearance.
  • Severely Impaired Liver Function: Use requires caution.
  • Cardiovascular Disease / Seizure History: Use requires specific caution, as outlined in official labeling.

Older adults may require lower initial doses, particularly if signs of renal impairment are present.

What should I know about interactions with other medicines?

Tamedin (cimetidine) is known to interact with a broad range of other medicinal products, primarily by slowing down their breakdown in the liver. This effect is due to its action as a potent inhibitor of certain Cytochrome P450 (CYP450) enzymes, which are essential for drug metabolism. This inhibition can lead to increased blood levels of co-administered drugs, raising the potential for toxicity or increased side effects.

Clinically Significant Interactions

The most commonly listed interacting medicines with a narrow therapeutic index, where close monitoring or dose adjustment is required, include warfarin (an anticoagulant), phenytoin (an anticonvulsant), and theophylline (for respiratory conditions). Concomitant use with warfarin may increase the risk of bleeding due to elevated warfarin levels.

Other categories of medicines that may be affected include certain antiarrhythmics (e.g., lidocaine, procainamide), some beta-blockers (e.g., propranolol, metoprolol), benzodiazepines (e.g., diazepam, chlordiazepoxide), and tricyclic antidepressants.

Absorption-Related Interactions

Antacids may decrease the absorption of Tamedin when taken at the same time; official advice often recommends spacing administration by two hours. Tamedin also increases stomach pH and can therefore reduce the absorption and effectiveness of pH-dependent medicines, such as ketoconazole (an antifungal).

Consultation with a healthcare professional is essential before combining Tamedin with any other prescription or over-the-counter medicine.

Mechanism of Action

Targeted Histamine H2-Receptor Blockade

The mechanism of Cimetidine centers on its role as a competitive antagonist at the Histamine H2-Receptor, which is abundantly expressed on the gastric parietal cells. By binding to this site, Cimetidine occupies the receptor and prevents the key activating signal normally delivered by the natural mediator, histamine. This action initiates the inhibition of the parietal cell's acid-secreting activity.


Modulating the Gastric Secretion Pathway

The H2-receptor blockade triggers a mechanistic cascade of inhibition that interrupts the cell's internal process for acid production. This modification of the signaling dynamics leads to a direct and sustained diminution of H^+ ion efflux (hydrochloric acid) into the stomach lumen. The resulting physiological consequence is an elevation of the gastric pH.

Dosage and Administration Information

Tamedin (Cimetidine) is administered through three routes: oral (using tablets or liquid solution), intravenous (IV), and intramuscular (IM) injection. The specific use pattern—including the dose and frequency—follows established patterns based on the required duration of use.

For oral use, standard adult short-term regimens include an 800 mg dose taken once daily at bedtime, or a divided dose of 300 mg administered four times per day, typically with meals and at bedtime. Short-term treatment usually runs for a period of four to eight weeks, after which the regimen may transition to long-term maintenance use, which is typically 400 mg once daily at bedtime. Oral doses may be taken with or immediately following a meal to align with the frequency pattern.

In non-oral administration, the usual dose is 300 mg administered every 6 to 8 hours. The total daily dose by any route should not normally exceed 2,400 mg. The parenteral solution requires dilution prior to intravenous administration, which must be performed slowly over a minimum of five minutes for IV injection or over 15 to 20 minutes for intermittent infusion. Instructions mandate a dose reduction for individuals with renal impairment, with the exact adjusted dose depending on the measured creatinine clearance. This ensures the medicine is administered within standardized, label-based conditions.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Tamedin


Research on Healing and Maintenance for Ulcer Conditions

The active ingredient in Tamedin, Cimetidine, was studied for its role primarily in short-term Randomized Controlled Trials (RCTs). These studies were evaluated in research exploring conditions characterized by fluctuating or episodic manifestations, specifically duodenal and benign gastric ulcers. Researchers monitored how healing rates were measured and recurrence patterns were assessed. The studies focused on adults with confirmed ulcers. Researchers monitored outcomes related to physical discomfort, such as patient-reported outcomes describing perceived discomfort and pain relief, alongside objective measures, such as documentation of the endoscopic rate of ulcer closure.

Studies explored the use of the active ingredient for long-term maintenance therapy following initial closure. These longer-term studies, which sometimes lasted up to a year or more, were applied in studies examining patient-reported experiences. There is limited information for long-term outcomes after maintenance studies concluded, and follow-up durations were limited in the initial healing trials (typically 4 to 8 weeks).


Evidence for Managing Erosive Reflux Disease

Tamedin was studied for its use in Gastroesophageal Reflux Disease (GERD) and erosive esophagitis, which are conditions associated with acute or disruptive episodes. Research primarily involved short- to intermediate-term Randomized Controlled Trials (RCTs), with subsequent meta-analyses used in research exploring how symptoms change over time. Outcomes included patient-reported outcomes describing perceived discomfort and objective outcomes like the documentation of mucosal integrity changes.

Findings indicate patterns in the documentation of mucosal integrity changes by repeat endoscopy over the 8- to 12-week study duration. However, the outcomes related to systemic or functional imbalance, such as changes in the pressure of the lower esophageal sphincter, findings were mixed across the different trials. The evidence derived from settings with varying symptom burdens appears to be less consistent.


Key Limitations and Areas of Uncertainty

The evidence highlights what is known—and what is still uncertain. Major limitations include that the follow-up durations were limited in many initial closure and symptomatic change trials. While the active ingredient was studied for its role extensively, some of the original evidence base is historic, meaning comparative evidence is lacking or less direct against modern standard-of-care therapies. Research does not determine whether an individual will respond similarly to the group patterns reported. These limitations mean that the current research provides context but does not describe personal outcomes.

Key Studies & References Cimetidine tablet, film coated, oral solution, injection: DailyMed Drug Label Information

Frequently Asked Questions (FAQ)

Common questions about Tamedin (FAQ)

Q: How quickly should I expect Tamedin to start working?

A: According to official product information, Tamedin's effects begin shortly after administration. Peak blood levels, which correspond to the maximum effect, are typically reached within 45 to 90 minutes after taking an oral dose.


Q: Can Tamedin be crushed or split?

A: Official information generally advises that patients swallow the oral tablets whole. The practice of modifying the tablet, such as crushing or splitting, is a decision that falls under professional medical guidance.


Q: What does official research say about the long-term use of Tamedin?

A: Tamedin has been studied for use in long-term maintenance regimens, with some research exploring use for periods up to five years for conditions like healed duodenal ulcers. Official information notes that long-term use of one month or more has been associated with specific side effects, such as gynecomastia.


Q: Is it common to feel a little sick when first starting Tamedin?

A: The safety profile lists gastrointestinal effects, including nausea, vomiting, and diarrhea, as common side effects. These reactions have been documented to occur in approximately 1% to 10% of patients in clinical data.


Q: What are the signs of a serious, but rare, side effect of Tamedin?

A: Official patient warnings describe certain serious adverse reactions, which are rare. These can include signs such as bloody or tarry stools, vomit that resembles coffee grounds, and changes in mental state, like confusion or hallucinations. Documentation notes that if these or other unusual reactions, such as breast swelling or tenderness, occur, professional medical attention may be warranted.


Q: What is the difference between the brand name and generic Tamedin?

A: Tamedin is a brand name for the active chemical compound cimetidine. The generic name, cimetidine, refers to the exact same active substance, which is required to meet the same quality and efficacy standards as the brand name product.


Q: Is Tamedin affected by whether I take it with or without food?

A: The official product information indicates that oral doses may be taken with or immediately following a meal. For preventing symptoms, the over-the-counter preparation is sometimes advised to be taken shortly before consuming foods or drinks that might cause heartburn.


Q: Is Tamedin a painkiller?

A: No, Tamedin is classified as a Histamine H2-receptor antagonist, which means its primary purpose is to reduce stomach acid production. Regulatory information specifically notes that this medicine is not an anti-inflammatory pain reliever.


Q: How long does the effect of one dose of Tamedin last?

A: Official studies indicate that following a single dose, blood concentrations remain high enough to suppress basal gastric acid secretion for approximately four to five hours.


Q: Can Tamedin be used for anything other than its main prescribed use?

A: The medicine is approved for several uses beyond initial ulcer treatment. These official indications include the healing and maintenance of ulcers, treatment of erosive GERD (reflux disease), and the management of conditions where the stomach produces too much acid (hypersecretory states).


Q: Are there any known issues with taking Tamedin and alcohol?

A: Official patient instructions advise against consuming alcohol while using Tamedin. This is because alcohol is known to increase irritation in the stomach, which could potentially hinder the healing process for conditions like ulcers.


Q: Can Tamedin affect birth control pills?

A: Tamedin is known to interfere with certain liver enzymes ( CYP450) that break down many other medicines, including hormonal components. The decision to combine Tamedin with hormonal contraceptives requires consideration by a healthcare professional.


Q: Why is Tamedin taken at a specific time of day?

A: Studies on Tamedin have shown that taking the full daily dose at bedtime can significantly reduce acid activity for up to eight hours during the night. This timing is utilized to maximize the suppression of nocturnal acid secretion.


Q: Is Tamedin usually taken short-term or long-term?

A: Tamedin is used in both short-term and long-term treatment strategies. Short-term use is typically for initial healing (such as four to eight weeks for active ulcers), and long-term use is for ongoing maintenance therapy to help prevent recurrence.


Q: Is Tamedin safe to use with heart medication?

A: Tamedin is documented to interact with certain medicines used for the heart and blood pressure, including some beta-blockers and antiarrhythmics. All concomitant medications should be reviewed by a healthcare professional before Tamedin is used.


Q: Are there any laboratory tests required before or during Tamedin use?

A: For patients with impaired kidney function, regulatory guidelines require dose reduction and increased caution. This often involves the monitoring of kidney function tests, such as creatinine clearance, prior to or during treatment.


Q: What is the risk of an allergic reaction to Tamedin?

A: The medicine is formally contraindicated for individuals with a known hypersensitivity to the compound. Official frequency data documents allergic reactions as rare, meaning they are reported in 0.01% to 0.1% of patients.


Q: Does Tamedin affect blood sugar levels?

A: Pharmacological studies have observed that Tamedin inhibits the gastric acid secretion that can be triggered by several factors, including the body's natural response to insulin.


Q: Can Tamedin be used by children?

A: The over-the-counter form of Tamedin is indicated for use in adults and children 12 years of age and over. Use for any child under 12 years old requires professional medical consultation.


Q: What are the ingredients in Tamedin besides the active substance?

A: The active substance is cimetidine. Official labels list several inactive ingredients, which may include components like cellulose, corn starch, and specific colorants or coatings that help form the tablet.


Q: How long does Tamedin stay in your system after stopping treatment?

A: Pharmacokinetic data shows that the elimination half-life of Tamedin is approximately two hours. This is the time it takes for the amount of medicine in the bloodstream to be reduced by half.


Q: Can Tamedin cause difficulty sleeping?

A: The safety profile documents adverse effects on the Central Nervous System (CNS) such as drowsiness (somnolence), dizziness, confusion, and hallucinations. These types of effects may influence a patient's sleep quality or patterns.


Q: Are there different strengths available for Tamedin?

A: Yes, Tamedin is made available in several strengths to accommodate different conditions. These include oral tablet strengths of 200 mg, 300 mg, 400 mg, and 800 mg, as well as a liquid solution.


Q: Can I take Tamedin if I have high blood pressure?

A: The use of Tamedin in individuals with high blood pressure requires professional medical consideration due to known drug interactions with specific blood pressure medicines, such as nifedipine and propranolol.


Q: Is it normal to have vivid dreams while taking Tamedin?

A: While vivid dreams are not specifically listed, the safety documentation does report rare Central Nervous System (CNS) effects, including confusion and hallucinations, which relate to altered mental and sleep states.


Q: Can Tamedin affect my ability to drive or operate machinery?

A: The official safety profile lists common side effects such as dizziness and drowsiness (somnolence). These effects may impair a person's ability to drive or operate complex machinery safely.


Q: Can Tamedin be prescribed for people who have epilepsy?

A: Official labeling advises specific caution for individuals with a prior history of seizures. Furthermore, Tamedin is known to interact with certain anticonvulsant medicines used to treat conditions like epilepsy, such as phenytoin.


Q: What are the main goals of Tamedin treatment?

A: Depending on the condition, the overall treatment goals include the healing of active ulcers, alleviating symptoms related to GERD, and achieving a substantial reduction in the production of stomach acid in hypersecretory states.


Q: What is the chance of getting a common side effect from Tamedin?

A: Side effects that are officially classified as 'common' are those that have been reported in clinical data with a frequency range of 1% to 10% of patients.


Q: Does taking Tamedin require routine monitoring?

A: While routine laboratory monitoring for the drug itself is not universally mandated, specialized monitoring of kidney function may be necessary for patients with renal impairment, and monitoring of interacting drugs (such as warfarin) is required.


Q: Can Tamedin interact with common vitamins?

A: Official patient information indicates that Tamedin may cause a decrease in Vitamin B12 levels. Information regarding all vitamins and supplements used by the patient is typically reviewed by a healthcare team to ensure safety.


Q: What information is provided about Tamedin's use in younger adults?

A: Prescription dosing is established for people 16 years and older for approved conditions. The over-the-counter preparation is indicated for individuals 12 years of age and older.


Q: What kind of foods or drinks should be avoided while taking Tamedin?

A: In general, the FDA advises that foods and drinks known to trigger heartburn, such as rich, spicy, fatty, and fried foods, caffeine, and alcohol, should be avoided as they may aggravate the underlying acid-related condition.

How should Tamedin be stored and disposed of?

The storage and disposal of Tamedin (Cimetidine) must strictly adhere to regulatory requirements to ensure product integrity and public safety.

Storage Conditions

Requirement Official Statement
Temperature Store at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F).
Protection Must be protected from light and moisture; store in a cool, dry, and dark place.
Container Keep the medicine in its original container and ensure the container is tightly closed.
Child Safety Keep out of the sight and reach of children (Store locked up).

Disposal Instructions

Disposal of unused or expired Tamedin must follow local, regional, and national regulations. To prevent environmental release, the product should not be discarded into any sewer or body of water. It is advised to use community drug take-back programs when available. If take-back is not an option, the US FDA advises mixing the medicine with an undesirable substance before placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tamedin found in:

A-Z Index: